Search

Your search keyword '"Seguier, Julie"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Seguier, Julie" Remove constraint Author: "Seguier, Julie" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
38 results on '"Seguier, Julie"'

Search Results

1. Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)

2. Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT

5. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

7. Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study

9. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review

11. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France

14. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

15. Tocilizumab versus anakinra in COVID-19: results from propensity score matching

16. Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated withEPHB4pathogenic variants

17. Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with EPHB4 pathogenic variants.

18. Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients

19. Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

20. Additional file 4 of Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT

21. Development and validation of a quality of life measurement scale specific to Hereditary Hemorrhagic Telangiectasia: The QoL-HHT

22. Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review

24. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

26. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

27. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia

28. Acute severe hepatitis in adult-onset Still’s disease: case report and comprehensive review of a life-threatening manifestation

29. Unexpected Association between Health-Related Quality of Life and the Blood Interferon Modular Transcriptional Signatures in Patients with Systemic Lupus Erythematosus

30. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus

31. Manifestations auto-immunes associées aux syndromes myélodysplasiques : description d'une cohorte régionale et revue de la littérature

32. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus.

33. Intravenous immunoglobulin in patients with acquired Von Willebrand syndrome: A single referral centre experience

36. 0082: Multimodality imaging in cardiac amyloidosis: respective contributions of echocardiography, MRI and scintigraphy

37. Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients.

38. Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab.

Catalog

Books, media, physical & digital resources